 Cell Survival
"Cell Survival" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability.
| Descriptor ID |
D002470
|
| MeSH Number(s) |
G04.346
|
| Concept/Terms |
Cell Survival- Cell Survival
- Survival, Cell
- Cell Viability
- Cell Viabilities
- Viabilities, Cell
- Viability, Cell
|
Below are MeSH descriptors whose meaning is more general than "Cell Survival".
Below are MeSH descriptors whose meaning is more specific than "Cell Survival".
This graph shows the total number of publications written about "Cell Survival" by people in this website by year, and whether "Cell Survival" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 4 | 1 | 5 | | 1992 | 1 | 2 | 3 | | 1993 | 0 | 9 | 9 | | 1994 | 0 | 6 | 6 | | 1995 | 1 | 4 | 5 | | 1996 | 1 | 15 | 16 | | 1997 | 0 | 6 | 6 | | 1998 | 0 | 8 | 8 | | 1999 | 0 | 10 | 10 | | 2000 | 1 | 19 | 20 | | 2001 | 1 | 18 | 19 | | 2002 | 3 | 23 | 26 | | 2003 | 0 | 20 | 20 | | 2004 | 4 | 27 | 31 | | 2005 | 2 | 25 | 27 | | 2006 | 2 | 32 | 34 | | 2007 | 0 | 27 | 27 | | 2008 | 2 | 36 | 38 | | 2009 | 6 | 42 | 48 | | 2010 | 2 | 36 | 38 | | 2011 | 2 | 41 | 43 | | 2012 | 0 | 49 | 49 | | 2013 | 1 | 46 | 47 | | 2014 | 1 | 41 | 42 | | 2015 | 0 | 37 | 37 | | 2016 | 0 | 29 | 29 | | 2017 | 0 | 32 | 32 | | 2018 | 0 | 26 | 26 | | 2019 | 3 | 28 | 31 | | 2020 | 0 | 9 | 9 | | 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cell Survival" by people in Profiles.
-
Andrysik Z, Bender H, Galbraith MD, Espinosa JM. Multi-omics analysis reveals contextual tumor suppressive and oncogenic gene modules within the acute hypoxic response. Nat Commun. 2021 03 02; 12(1):1375.
-
Das D, Koirala N, Li X, Khan N, Dong F, Zhang W, Mulay P, Shrikhande G, Puskas J, Drazba J, McLennan G. Screening of Polymer-Based Drug Delivery Vehicles Targeting Folate Receptors in Triple-Negative Breast Cancer. J Vasc Interv Radiol. 2020 11; 31(11):1866-1873.e2.
-
Thomé CH, Ferreira GA, Pereira-Martins DA, Dos Santos GA, Ortiz CA, de Souza LEB, Sobral LM, Silva CLA, Scheucher PS, Gil CD, Leopoldino AM, Silveira DRA, Coelho-Silva JL, Traina F, Koury LC, Melo RAM, Bittencourt R, Pagnano K, Pasquini R, Nunes EC, Fagundes EM, Gloria ABF, Kerbauy FR, Chauffaille ML, Keating A, Tallman MS, Ribeiro RC, Dillon R, Ganser A, Löwenberg B, Valk P, Lo-Coco F, Sanz MA, Berliner N, Faça VM, Rego EM. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia. Sci Rep. 2020 06 25; 10(1):10315.
-
Farkhondeh T, Mehrpour O, Buhrmann C, Pourbagher-Shahri AM, Shakibaei M, Samarghandian S. Organophosphorus Compounds and MAPK Signaling Pathways. Int J Mol Sci. 2020 Jun 15; 21(12).
-
Brózman O, Novák J, Bauer AK, Babica P. Airborne PAHs inhibit gap junctional intercellular communication and activate MAPKs in human bronchial epithelial cell line. Environ Toxicol Pharmacol. 2020 Oct; 79:103422.
-
Matheson CJ, Casalvieri KA, Backos DS, Minhajuddin M, Jordan CT, Reigan P. Substituted oxindol-3-ylidenes as AMP-activated protein kinase (AMPK) inhibitors. Eur J Med Chem. 2020 Jul 01; 197:112316.
-
Germano A, Rossin D, Leoni V, Iaia N, Saba L, Basile V, Puglisi S, Caccia C, Poli G, Biasi F, Terzolo M. Involvement of 27-Hydroxycholesterol in Mitotane Action on Adrenocortical Carcinoma. Cells. 2020 04 04; 9(4).
-
Fitzsimmons LF, Liu L, Kant S, Kim JS, Till JK, Jones-Carson J, Porwollik S, McClelland M, Vazquez-Torres A. SpoT Induces Intracellular Salmonella Virulence Programs in the Phagosome. mBio. 2020 02 25; 11(1).
-
Tarullo SE, Hill RC, Hansen KC, Behbod F, Borges VF, Nelson AC, Lyons TR. Postpartum breast cancer progression is driven by semaphorin 7a-mediated invasion and survival. Oncogene. 2020 03; 39(13):2772-2785.
-
Harrold AP, Cleary MM, Bharathy N, Lathara M, Berlow NE, Foreman NK, Donson AM, Amani V, Zuercher WJ, Keller C. In vitro benchmarking of NF-?B inhibitors. Eur J Pharmacol. 2020 Apr 15; 873:172981.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|